Immediate Impact
1 by Nobel laureates 6 from Science/Nature 62 standout
Citing Papers
Cancer therapy with antibodies
2024 Standout
Nanomedicine Remodels Tumor Microenvironment for Solid Tumor Immunotherapy
2024 Standout
Works of Yan Yu being referenced
Phase I/II combination study of tifcemalimab with toripalimab in patients with refractory extensive stage small cell lung cancer (ES-SCLC).
2023
Matrine suppresses lung cancer metastasis via targeting M2-like tumour-associated-macrophages polarization.
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yan Yu | 705 | 441 | 206 | 327 | 61 | 1.4k | |
| Li-Peng Hu | 964 | 553 | 234 | 500 | 67 | 2.1k | |
| Liang Jin | 777 | 688 | 261 | 320 | 65 | 1.9k | |
| Hao Chen | 675 | 462 | 515 | 447 | 76 | 1.9k | |
| Xiuqin Wang | 877 | 221 | 103 | 226 | 93 | 2.0k | |
| Yuhong Wang | 837 | 256 | 234 | 335 | 68 | 1.7k | |
| Zhifei Xu | 730 | 304 | 321 | 189 | 97 | 1.6k | |
| Sajni Josson | 1027 | 344 | 301 | 851 | 24 | 1.7k | |
| Na Song | 684 | 327 | 142 | 243 | 74 | 1.6k | |
| Diane Wang | 710 | 642 | 324 | 81 | 92 | 2.1k | |
| Dan Lu | 768 | 790 | 92 | 122 | 63 | 1.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...